Fulcrum Therapeutics Inc (FULC) — Cash Flow Quality Index
Latest as of June 2024:
1.06x
Fulcrum Therapeutics Inc (FULC) has a Cash Flow Quality Index of 1.06x as of June 2024. Operating cash flow of $58.90 Million exceeds net income of $55.41 Million, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Fulcrum Therapeutics Inc generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
1.06x
Operating CF / Net Income
Operating Cash Flow
$58.90 Million
USD
Net Income
$55.41 Million
USD
Data as of
Jun 2024
Most recent filing
Annual Cash Flow Quality Index for Fulcrum Therapeutics Inc (None–None)
Year-by-year earnings quality comparison for Fulcrum Therapeutics Inc. For live market cap and the full company financial profile, see how much is Fulcrum Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.